1. Home
  2. Advent International

Category: SOBI

Advent, GIC withdraw $8bn bid for Swedish drugmaker Orphan Biovitrum

Agnafit Bidco, set up by private equity major Advent International and Aurora, the investment vehicle of Singapore's GIC, has withdrawn an $8bn bid for Swedish drugmaker Orphan Biovitrum (SOBI). The post Advent, GIC withdraw $8bn

Booming rare disease drugmaker SOBI valued at $8bn through Advent, GIC buyout offer

Advent International and Singapore sovereign investor GIC have offered to buy booming rare-disease drugmaker Swedish Orphan Biovitrum in a deal valuing the business at about $8bn. The post Booming rare disease drugmaker SOBI valued at

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.